Cardiacsense Ltd.
USPTO PatentsView assignee record - 8 granted patents across 1 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Cardiacsense ranks #31,134 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 1 technology areas.
- #31,134
- of 49,997 US assignees by volume
- 43rd percentile
- by Innovation Score (33.1/100)
- 8.9
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R31134 · Foreign Corporation #31,134 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 8 grants
- MID-PACK #31,134/49,997
- PHOTO-FINISH Cambrian Innovation
- CPC-NARROW A61B · 1 areas
- INNOV-THIN 33.1/100
- CLAIMS-PAR 8.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Cambrian Innovation, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cardiacsense’s 33.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cardiacsense
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cardiacsense · this assignee 33
Cardiacsense · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cardiacsense's Innovation Score is 33.1/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cardiacsense?
Each dot is one of Cardiacsense’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cardiacsense’s own 8.9 claims/patent is at or below the 20.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Cardiacsense's grants concentrate
Cardiacsense Ltd. is a focused PatentsView assignee: 1 CPC subclasses with 62.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (3 grants) versus a trough of 2 in 2020. By volume, Cardiacsense sits between Cambrian Innovation, Inc. and Cass Informations Systems, Inc..
Cardiacsense's three-year grant acceleration
Cardiacsense Ltd. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Cardiacsense's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cambrian Innovati…
Cambrian Innovation, Inc.
8 patents
- Cambridge Researc…
Cambridge Research & Instrumentation, Inc.
8 patents
- Canon Solutions A…
Canon Solutions America, Inc.
8 patents
- Car-o-liner Group…
Car-O-Liner Group AB
8 patents
- Cardiokinetix
CardioKinetix, Inc.
8 patents
- Carlson Software
Carlson Software, Inc.
8 patents
- Carolina Moldings
Carolina Moldings, Inc.
8 patents
- Cass Informations…
Cass Informations Systems, Inc.
8 patents
- Cardiacsense ◀
Cardiacsense Ltd.
8 patents
What this shows Cardiacsense holds 8 patents at rank #31,249, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cardiacsense
By rank, the assignees closest to #31,249 in granted patent volume.
- Cambrian Innovation, Inc. #31,245 · 8 patents
- Cambridge Research & Instrumentation, Inc. #31,246 · 8 patents
- Canon Solutions America, Inc. #31,247 · 8 patents
- Car-O-Liner Group AB #31,248 · 8 patents
- CardioKinetix, Inc. #31,250 · 8 patents
- Carlson Software, Inc. #31,251 · 8 patents
- Carolina Moldings, Inc. #31,252 · 8 patents
- Cass Informations Systems, Inc. #31,253 · 8 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Cardiacsense's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Cardiacsense's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 43rd percentile higher than 43% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 25.0% |
| 2023 | 3 | 37.5% |
| 2024 | 2 | 25.0% |
| 2025partial year | 1 | 12.5% |
Which technologies does Cardiacsense Ltd. patent most?
Top 1 of 1 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Cardiacsense Ltd.'s patent record in context - here's where to go next.
- Cardiacsense Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 62.5% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #31,134 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Cardiacsense Ltd. against Cambrian Innovation, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.